Novarum DX
Novarum DX is an Edinburgh-based private health-technology company, founded in 2012, that builds software turning smartphones into mobile medical test readers. Its RARE SaaS platform serves B2B enterprise customers with organizational onboarding and cloud-based diagnostic workflows.
- Company typePrivate
- Founded2012
- HeadquartersEdinburgh, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Novarum DX firmographics
Firmographics- Name
- Novarum DX
- Website
- https://novarumdx.com
- Company type
- Private
- Founded year
- 2012
- Headcount range
- 11–50 employees
- Short description
- Novarum DX is an Edinburgh-based private health-technology company, founded in 2012, that builds software turning smartphones into mobile medical test readers. Its RARE SaaS platform serves B2B enterprise customers with organizational onboarding and cloud-based diagnostic workflows.
- Ownership category
- akta.pro rank
Novarum DX industry classification
Industry- Product category
- Mobile Medical Diagnostics Software
- NAICS
- Software Publishers (5132), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO), DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)
Keywords
Where Novarum DX is headquartered
LocationHeadquarters
- HQ city
- Edinburgh
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Novarum DX business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Operations
Novarum DX product offering
Product offeringCore offering
Novarum DX develops software that converts smartphones into mobile medical test readers, enabling diagnostic testing workflows on consumer-grade mobile devices. The company's current product surface is RARE, a cloud-based SaaS platform (version 2.0.0) offering user authentication and account management for organizational users.
Differentiator
Problem solved
Functional benefit
Products and services
- RARE RARE is Novarum DX's cloud-based SaaS platform for mobile medical diagnostics. It provides web-based user authentication (sign-in, password reset, and new account registration with mandatory organization name) and is delivered as a managed software service for organizational users. It is currently at version v2.0.0.
Companies that use Novarum DX
Customer profileIdeal customer profiles1 record
Novarum DX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Novarum DX competitors and assessment
Company assessmentEmerging players
- Eko Health: Eko combines connected stethoscope hardware with AI/ML auscultation software on smartphones, representing a comparable smartphone-centric SaMD business model to Novarum DX.
- AliveCor: AliveCor's KardiaMobile uses a smartphone-connected sensor and AI-based ECG analysis; while focused on cardiac rather than lateral-flow tests, it shares the SaMD-on-smartphone model and FDA-cleared mobile diagnostic positioning.
- Qure.ai: Qure.ai applies AI/ML imaging analysis to medical scans (chest X-ray, head CT), positioning it as an AI-based SaMD imaging and signal-analysis peer to Novarum DX's image-based medical test reading software.
- Genalyte: Genalyte has developed a smartphone-/cloud-connected immunoassay platform that interprets diagnostic results digitally, overlapping Novarum DX's decentralized, software-driven diagnostic reader approach.
- Nuclein: Nuclein is building fully self-contained, rapid molecular diagnostics for point-of-care and at-home use with mobile-app-driven result interpretation, sharing Novarum DX's mobile-first decentralized testing thesis.
Direct peers
- Healthy.io: Healthy.io turns smartphone cameras into clinical-grade diagnostic test readers (e.g., urinalysis, wound care, prenatal), making it the closest direct peer to Novarum DX's smartphone-based mobile medical test reading model.
- Scanwell Health: Scanwell develops smartphone-based at-home diagnostic tests paired with a mobile app that interprets results using computer vision, directly overlapping Novarum DX's value proposition of turning smartphones into medical test readers.
- Abionic: Abionic offers rapid point-of-care diagnostics with a smartphone-connected nanofluidic platform, sharing Novarum DX's positioning at the intersection of mobile devices and decentralized clinical testing.
Broad incumbents
- Bühlmann Laboratories (CALEX range): Bühlmann is an established diagnostics manufacturer whose CALEX range pairs fecal calprotectin sample prep with smartphone-based reading via an app — an example of an incumbent IVD player adding a smartphone reader workflow similar to Novarum DX's RARE.
- EKF Diagnostics: EKF Diagnostics sells point-of-care and clinical chemistry devices and has integrated smartphone-based result capture in some workflows, making it a broad incumbent operating adjacent to Novarum DX's mobile reader approach.
Market position
Customer concentration
Novarum DX social profiles
Digital presenceNovarum DX financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novarum DX leadership team
Management profileNumber of profiles
Novarum DX funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novarum DX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novarum DX
What does Novarum DX do?
Novarum DX develops software that converts smartphones into mobile medical test readers, enabling diagnostic testing workflows on consumer-grade mobile devices. The company's current product surface is RARE, a cloud-based SaaS platform (version 2.0.0) offering user authentication and account management for organizational users.
When was Novarum DX founded?
Novarum DX was founded in 2012. It employs 11 to 50 people.
Where is Novarum DX based?
Novarum DX is headquartered in Edinburgh, United Kingdom, in the Europe region.
Who are Novarum DX's main competitors?
Emerging players on record are Eko Health, AliveCor, Qure.ai, Genalyte and Nuclein. Direct peers are Healthy.io, Scanwell Health and Abionic. Broad incumbents are Bühlmann Laboratories (CALEX range) and EKF Diagnostics.
Does Novarum DX have an API?
No public API is recorded for Novarum DX.
What industry is Novarum DX in?
Novarum DX's product category is Mobile Medical Diagnostics Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement. Its NAICS code is 5132 and its SIC code is 3841.